Erin Gordon

Erin Gordon, MD is an Associate Professor at the School of Medicine, University of California, San Francisco (UCSF). Her research focuses on airway epithelial dysfunction in asthma, particularly how genetic risk variants translate to molecular disease mechanisms. Using conditionally reprogrammed cells, CRISPR, and human biospecimens, her work aims to identify novel drug targets and subpopulations of asthmatics who may benefit from targeted therapies.

• Education: B.A. in Molecular Cell Biology (UC Berkeley, 2001), M.D. (USC, 2005), Internal Medicine Residency (UCSD), Pulmonary & Critical Care Fellowship (UCSF).
• Grants: NIH R01AI136962 (2018-2022), K08HL114645 (2013-2018), F32HL107004 (2011).
• Research Networks: Collaborations with researchers like Maya Kotas, John Fahy, and Prescott Woodruff across UCSF and other UC institutions.
• Article Trends: Recent publications emphasize genetic mechanisms in asthma, epithelial-immune interactions, and therapeutic innovations in pulmonary diseases.